how much weight loss is expected with tirzepatide Mounjaro® by Week How Much Weight Can You

GLP-1 receptor agonists are a class of injectable and oral medications that: Stimulate the GLP-1 receptor to increase insulin secretion and suppress glucagon

Scientists have been studying its effects on everything from wound healing to skin regeneration, and the results are consistently impressive

Established risk factors for venous thromboembolism (VTE) include: Obesity (BMI 30 kg/m), which increases venous stasis and pro-inflammatory states Immobility or reduced mobility , particularly relevant in patients with severe obesity Previous history of VTE or family history of thrombophilia Active malignancy or recent surgery Hormonal therapies , including combined oral contraceptives or hormone replacement therapy Pregnancy and the postpartum period Smoking , which affects endothelial function and coagulation Risk factors for arterial thrombosis (myocardial infarction, stroke) include: Type 2 diabetes mellitus , associated with endothelial dysfunction, platelet hyperreactivity, and a prothrombotic state Hypertension , causing arterial wall damage Dyslipidaemia , promoting atherosclerotic plaque formation Established cardiovascular disease Chronic kidney disease , common in diabetes and associated with increased cardiovascular risk Patients initiating GLP-1 therapy should undergo a comprehensive cardiovascular risk assessment

Blocked intestines, known clinicially as ileus, is a serious and potentially fatal condition

In recent years, GLP-1 medications have emerged as promising solutions for weight loss

Family neighborhoods where sick-day support and wellness maintenance are priorities